Opinion

Video

An Overview of Potential Treatment Adverse Effects

An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.

Video content above is prompted by the following question(s):

  • What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
  • How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
  • What guidance do you offer to patients to assist them in effective management of potential adverse events?
Related Videos
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Image of man with brown hair.
Image of a man wearing a black button-up shirt.